Abstract
A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.
Original language | English |
---|---|
Pages (from-to) | 2218-2220 |
Number of pages | 3 |
Journal | Emerging infectious diseases |
Volume | 10 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2004 Dec |
All Science Journal Classification (ASJC) codes
- Epidemiology
- Microbiology (medical)
- Infectious Diseases